Skip to main content
. 2021 Oct 21;126(5):706–717. doi: 10.1038/s41416-021-01485-9

Table 2.

Key randomised controlled trial (RCT) evidence base comparing minimally invasive oesophagectomy (MIO), a hybrid approach, and robot-assisted minimally invasive oesophagectomy (RAMIE) with open transthoracic surgery.

Trial Comparison Arm A Arm B P Other comments
MIRO [15] N = 207 Arm A: open TTO Arm B: Hybrid 2 resection 64% major complications 30% pulmonary complications 36% major complications 18% pulmonary complications <0.001 Trends towards improved survival with hybrid approach, 3-year survival 67% hybrid versus 55% open, NS
TIME [102] N = 115 Arm A: MIO Arm B: open TTO 34% pulmonary infection (at 30 d) 9% pulmonary infection (at 30 d) 0.005 3-year survival 51.5% MIO versus 40.4% open (P = 0.02)
ROBOT [16, 108] N = 112 Arm A: open TTO Arm B: RAMIE 80% overall complications 59% overall complications P = 0.02 Reduced blood loss (P < 0.001) and pulmonary complications (P = 0.005), and improved functional recovery (P = 0.03) with RAMIE. 5-year survival 41% RAMIE, 40% open, NS

NS   non-significant, TTO transthoracic oesophagectomy.